Zobrazeno 1 - 10 of 86 pro vyhledávání: '"Ch, Geisler"'
2
Einfluss methodischer Varianten auf die Standardkurve bei Vitamin B12-Bestimmungen mit Lactobacillus leichmannii
Autor: Ch. Geisler, W. Oberzill
Publikováno v: Pathobiology. 36:193-199
Methodological parameters of the microbiological assay of vitamin B12 with Lb. leichmannii have been investigated. These involved chiefly temperature of incubation of bacteria and length of the incubation period. Both parameters affect standard curve
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::efcef8340d0f30b1a12d6be26fbb945d
https://doi.org/10.1159/000162448
Zobrazit plný text záznamu
4
Male gender is associated with an impaired overall and progression free survival in patients with prognostic low risk Chronic Lymphocytic Leukemia
Autor: Caspar da Cunha-Bang, Ch, Geisler, Enggaard, L., Cb, Poulsen, Peter De Nully Brown, Henrik Frederiksen, Bergmann, Olav J., Elisa Jacobsen Pulczynski, Pedersen, R. S., Nielsen, L. H., Christiansen, I., Cu, Niemann
Publikováno v: University of Southern Denmark
da Cunha-Bang, C, Geisler, C, Enggaard, L, Poulsen, C, Brown, P, Frederiksen, H, Bergmann, O, Pulczynski, E, Pedersen, R S, Nielsen, L, Christiansen, I & Niemann, C 2016, ' Male gender is associated with an impaired overall and progression free survival in patients with prognostic low risk chronic lymphocytic leukemia ', Haematologica, vol. 101, no. Suppl. 1, E1081, pp. 445 . < http://www.haematologica.org/content/101/s1/1.full.pdf+html >
da Cunha-Bang, C, Geisler, CH, Enggaard, L, Poulsen, CB, Brown, P D N, Frederiksen, H, Bergmann, O J, Pulczynski, E J, Pedersen, R S, Nielsen, L H, Christiansen, I & Niemann, CU 2016, ' Male gender is associated with an impaired overall and progression free survival in patients with prognostic low risk Chronic Lymphocytic Leukemia ', 21st European Haematology Association Congress, Copenhagen, Danmark, 09/06/2016-12/06/2016 .
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::7eac80b0540abfbd0117e7ee0b8ff24d
https://portal.findresearcher.sdu.dk/en/publications/d4308e56-9aba-452c-bd53-897ae7a5dac3
Zobrazit plný text záznamu
6
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
7
Editorial & Opinion
Prognosis of IGLV3-21 R110 chronic lymphocytic leukemia after chemotherapy-based treatment in a real-world analysis.
Autor: Hengeveld PJ; Department of Immunology, Erasmus MC, University Medical Centre Rotterdam, Rotterdam, the Netherlands.; Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, the Netherlands., Veelken H; Department of Hematology, Leiden University Medical Center, Leiden, the Netherlands., van Bergen CAM; Department of Hematology, Leiden University Medical Center, Leiden, the Netherlands., Quinten E; Department of Hematology, Leiden University Medical Center, Leiden, the Netherlands., Vervoordeldonk MYL; Department of Immunology, Erasmus MC, University Medical Centre Rotterdam, Rotterdam, the Netherlands., Ismailzada W; Department of Hematology, Leiden University Medical Center, Leiden, the Netherlands., Barendse RS; Department of Hematology, Leiden University Medical Center, Leiden, the Netherlands., Dubois JMN; Department of Hematology, Cancer Care Center Amsterdam, Amsterdam University Medical Centers, Amsterdam, the Netherlands., van Oers MHJ; Department of Hematology, Cancer Care Center Amsterdam, Amsterdam University Medical Centers, Amsterdam, the Netherlands., Geisler CH; Department of Hematology, Rigshospitalet, Copenhagen, Denmark., Kater AP; Department of Hematology, Cancer Care Center Amsterdam, Amsterdam University Medical Centers, Amsterdam, the Netherlands., Westerweel PE; Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, the Netherlands., Langerak AW; Department of Immunology, Erasmus MC, University Medical Centre Rotterdam, Rotterdam, the Netherlands., Levin MD; Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, the Netherlands. m-d.levin@asz.nl.
Publikováno v: Leukemia [Leukemia] 2023 Sep; Vol. 37 (9), pp. 1929-1932. Date of Electronic Publication: 2023 Jul 21.
Zobrazit plný text záznamu
8
Akademický článek
Assessing the Brighton Collaboration Case Definition of Sensorineural Hearing Loss in Ghana.
Autor: Bukari I; Global Health Program, College of Public Health, National Taiwan University, Taipei, Taiwan., Huang WT; Global Health Program, College of Public Health, National Taiwan University, Taipei, Taiwan.; National Taiwan University Children's Hospital, Taipei, Taiwan., Issahalq DM; Eye, Ear, Nose and Throat Department, Komfo Anokye Teaching Hospital, Kumasi, Ghana., Agyemang-Prempeh AA; Eye, Ear, Nose and Throat Department, Komfo Anokye Teaching Hospital, Kumasi, Ghana., Konney A; Eye, Ear, Nose and Throat Department, Komfo Anokye Teaching Hospital, Kumasi, Ghana., Yussif H; Public Health Department, Komfo Anokye Teaching Hospital, Kumasi, Ghana., Yakubu YA; Graduate Centre of Management, Cape Peninsula University of Technology, Cape Town, South Africa., Geisler CH; Pantang Hospital, Ghana Health Service, Accra, Ghana., Chen WJ; Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, Taipei, Taiwan.; Center for Neuropsychiatric Research, National Health Research Institutes, Miaoli, Taiwan.
Publikováno v: The American journal of tropical medicine and hygiene [Am J Trop Med Hyg] 2022 Oct 17; Vol. 107 (6), pp. 1351-1354. Date of Electronic Publication: 2022 Oct 17 (Print Publication: 2022).
Zobrazit plný text záznamu
9
Correction: Expression patterns and prognostic potential of circular RNAs in mantle cell lymphoma: a study of younger patients from the MCL2 and MCL3 clinical trials.
Autor: Dahl M; Department of Hematology, Rigshospitalet Copenhagen University Hospital, Copenhagen, Denmark.; Biotech Research and Innovation Centre, Copenhagen University, Copenhagen, Denmark.; Novo Nordisk Foundation Center for Stem Cell Biology, DanStem, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark., Husby S; Department of Hematology, Rigshospitalet Copenhagen University Hospital, Copenhagen, Denmark.; Biotech Research and Innovation Centre, Copenhagen University, Copenhagen, Denmark.; Novo Nordisk Foundation Center for Stem Cell Biology, DanStem, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark., Eskelund CW; Department of Hematology, Rigshospitalet Copenhagen University Hospital, Copenhagen, Denmark.; Biotech Research and Innovation Centre, Copenhagen University, Copenhagen, Denmark., Besenbacher S; Department of Molecular Medicine (MOMA), Aarhus University, Aarhus, Denmark., Fjelstrup S; Interdisciplinary Nanoscience Center (iNANO), Aarhus University, Aarhus, Denmark., Côme C; Department of Hematology, Rigshospitalet Copenhagen University Hospital, Copenhagen, Denmark.; Biotech Research and Innovation Centre, Copenhagen University, Copenhagen, Denmark.; Novo Nordisk Foundation Center for Stem Cell Biology, DanStem, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark., Ek S; Department of Immunotechnology, Lund University, Lund, Sweden., Kolstad A; Department of Oncology, Oslo University Hospital, Radiumhospitalet, Oslo, Norway., Räty R; Department of Hematology, Helsinki University Hospital, Helsinki, Finland., Jerkeman M; Division of Oncology, Lund University, Lund, Sweden., Geisler CH; Department of Hematology, Rigshospitalet Copenhagen University Hospital, Copenhagen, Denmark., Kjems J; Interdisciplinary Nanoscience Center (iNANO), Aarhus University, Aarhus, Denmark.; Department of Molecular Biology and Genetics, Aarhus University, Aarhus, Denmark., Kristensen LS; Department of Biomedicine, Aarhus University, Aarhus, Denmark. lasse@biomed.au.dk., Grønbæk K; Department of Hematology, Rigshospitalet Copenhagen University Hospital, Copenhagen, Denmark. kirsten.groenbaek@regionh.dk.; Biotech Research and Innovation Centre, Copenhagen University, Copenhagen, Denmark. kirsten.groenbaek@regionh.dk.; Novo Nordisk Foundation Center for Stem Cell Biology, DanStem, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark. kirsten.groenbaek@regionh.dk.
Publikováno v: Leukemia [Leukemia] 2022 Apr; Vol. 36 (4), pp. 1198.
Zobrazit plný text záznamu
10
Akademický článek
Pre-treatment health-related quality of life parameters have prognostic impact in patients >65 years with newly diagnosed mantle cell lymphoma: The Nordic Lymphoma Group MCL4 (LENA-BERIT) experience.
Autor: Lindberg Å; Department of Infectious Diseases, Lund University, Lund, Sweden.; Division of Medicine, Halland Hospital, Halmstad, Sweden., Eskelund CW; Department of Haematology, Rigshospitalet, Copenhagen, Denmark.; Biotech Research and Innovation Centre, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark., Albertsson-Lindblad A; Division of Oncology, Lund University, Lund, Sweden.; Skåne University Hospital, Lund, Sweden., Kolstad A; Department of Oncology, Oslo University Hospital, Oslo, Norway., Laurell A; Department of Oncology, Akademiska University Hospital, Uppsala, Sweden., Räty R; Department of Haematology, Helsinki University Hospital, Helsinki, Finland., Grønbaek K; Department of Haematology, Rigshospitalet, Copenhagen, Denmark.; Biotech Research and Innovation Centre, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark., Geisler CH; Department of Haematology, Rigshospitalet, Copenhagen, Denmark.; Biotech Research and Innovation Centre, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark., Jerkeman M; Division of Oncology, Lund University, Lund, Sweden.; Skåne University Hospital, Lund, Sweden.
Publikováno v: Hematological oncology [Hematol Oncol] 2022 Feb; Vol. 40 (1), pp. 22-30. Date of Electronic Publication: 2021 Nov 10.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje